 By Anita Dushyanth, PhD NASDAQ:INMB NASDAQ:NTRP TSX:PMN.TO Rethinking the approach to treat Alzheimers disease Both scientists and physicians are still wrestling with the idea of how to identify the biological drivers that are responsible for the early onset of neurodegenerative diseases. Alzheimers disease AD, in particular, is extremely challenging to treat because it develops slowly 